Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
32 hedge funds and large institutions have $17.9M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 4 closing their positions.
7,800% more call options, than puts
Call options by funds: $79K | Put options by funds: $1K
2% less capital invested
Capital invested by funds: $18.1M → $17.9M (-$278K)
3% less funds holding
Funds holding: 33 → 32 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$2.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$138K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$56.7K |
| 4 |
Jane Street
New York
|
+$16.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$187K |
| 2 |
Two Sigma Investments
New York
|
-$64K |
| 3 |
BC
BIT Capital
Berlin,
Germany
|
-$52.2K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$39K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$25.9K |
GRTX Hedge Fund Activity: Q4 2022 in Review
32 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q4 2022, worth a combined $17.9M — down 1.5% from $18.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GRTX and 3 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 6 added.
The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $2.7M. The largest seller was Renaissance Technologies, cutting an estimated $187K.
- 32 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q4 2022, down from 33 in Q3 2022.
- Funds reported $17.9M of Galera Therapeutics, Inc. Common Stock stock for Q4 2022, down 1.5% quarter-over-quarter.
- 3 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of -1 holder.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q4 2022 was Sectoral Asset Management, an estimated $2.7M added.
- The largest Galera Therapeutics, Inc. Common Stock seller in Q4 2022 was Renaissance Technologies, an estimated $187K sold.
Based on aggregated 13F filings for Q4 2022.